Training - ISoP Symposium & Training
ISoP Symposium and Training for Eurasia
Co-ordinator: Jean-Christophe Delumeau (ISoP Executive member).
Organized according to the Plan of Scientific and Practical Events of the Ministry of Healthcare of the Russian Federation, jointly by the Federal Service for Surveillance in Healthcare and the Russian Medical Academy of Continuous Professional Education.
This Symposium and Training is the first of its kind organised by ISoP for Healthcare Professionals involved in ensuring the safe use of medicines in the Eurasian Economic Union (EAEU) and other countries of the Eurasian area. The driving theme of this event is the Societal Importance of Pharmacovigilance in Eurasia and will aim to make all stakeholders better aware of the need to promote the behaviours leading to improved adverse event reporting.
This event will be occurring at the crucial time of a significant update of the EAEU Good Vigilance Practices. These practices are designed to prioritise pharmacovigilance activities in proportion to safety risks, implement consistency across National Regulatory Authorities, while utilising advanced analytic methods to safety data.
This event will be conducted on-line on June 4 and 5, then June 18 and 19. Each of those four days will be composed of 3 sessions of 90 minutes each with separated by 30-minute intermissions for relaxing. Overall, it will provide 12 hours of presentations and 6 hours of panel discussions.
This webinar is aimed to engage all interested pharmacovigilance professionals in an industry, regulatory, or university setting.
Training certificates will be provided by e-mail to those who complete the training.
The following themes will be developed during this Symposium & Training. Presentations will be given by speakers from the EAEU or by International Experts member of ISoP or appointed especially. English-Russian and Russian-English simultaneous translation will be provided.
|June 4||Committing HCPs and the Society to the Importance of Pharmacovigilance|
|Session 1A||The societal importance of pharmacovigilance in Eurasia|
|Session 1B||HCP’s and Patients commitment to the safe use of medicines|
|Session 1C||Improving the Safety Regulatory Framework in Eurasia|